CardioGenics Holdings Inc (CGNH)
CGNH Stock Price Chart
Explore CardioGenics Holdings Inc interactive price chart. Choose custom timeframes to analyze CGNH price movements and trends.
CGNH Company Profile
Discover essential business fundamentals and corporate details for CardioGenics Holdings Inc (CGNH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
9 Jun 2004
Employees
4.00
Website
https://www.cardiogenics.comCEO
Yahia Abdul Gawad Ch.B., MB,
Description
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
CGNH Financial Timeline
Browse a chronological timeline of CardioGenics Holdings Inc corporate events including earnings releases, dividend announcements, and stock splits.
CGNH Stock Performance
Access detailed CGNH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.